佳兆业集团(01638.HK)前7月总合约销售同比增加25.8%至400.38亿元
格隆汇8月9日丨佳兆业集团(01638.HK)公告,集团(连同其合营企业及联营公司)于2019年7月份录得约人民币53.48亿元的合约销售,按年减少约18%。2019年7月的合约建筑面积约为37.34万平方米,按年减少约8.2%。2019年7月的平均售价约为每平方米人民币14,321元,按年减少约10.6%。
集团于截至2019年7月31日止7个月的总合约销售约为人民币400.38亿元,总合约建筑面积约为233.49万平方米,分别较2018年同期增加约25.8%及28.1%。截至2019年7月31日止7个月的平均售价约为每平方米人民币17,147元,较2018年同期减少约1.8%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.